Net Cash Provided by (Used in) Operating Activities |
-422K |
USD |
+30.2% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
350K |
USD |
+16.7% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
85M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
46.4M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6K |
USD |
-86.4% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
41.8M |
USD |
+3.12% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
41.8M |
USD |
+3.12% |
Dec 31, 2023 |
Q4 2023 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-1.11M |
USD |
-51.6% |
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
1K |
USD |
0% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Dec 31, 2023 |
Q4 2023 |
Current State and Local Tax Expense (Benefit) |
1K |
USD |
0% |
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred State and Local Income Tax Expense (Benefit) |
-158K |
USD |
-42.3% |
Dec 31, 2023 |
Q4 2023 |
Interest Expense |
326K |
USD |
+279% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Dec 31, 2023 |
Q4 2023 |